Boston Scientific (BSX) valuation history
$42.69
Latest weekly close · Market cap $63.0B
Share BSX P/E history
Historically low
Boston Scientific's P/E of 17.3x is lower than 99% of its weekly readings over the last five years (as of ).
- Forward P/E 13.5× (analyst estimates, not ranked).
Weekly P/E with its 5-year range
P/E each weekMiddle half of the last 5 years5-year median 68.1×
- 5-year median
- 68.1×
- 10-year median
- 64.4×
- 5-year low to high
- 17.3× to 115.8×
- Versus 5-year median
- -75%
P/E
1stpercentile
of its weekly readings over the last five years
Growth, last 12 months vs the year before
- Revenue
- +14%decelerating
- EPS
- +47%
Price vs revenue and EPS, indexed to 100
Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.
PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading
P/E at each year-end
The last weekly reading of each year, and its percentile against the five years before it.
| Year-end | P/E | 5-year percentile |
|---|---|---|
| 50.7× | 4 | |
| 75.0× | 66 | |
| 70.5× | 59 | |
| 110.2× | 88 | |
| 55.2× | 57 | |
| 13.8× | 19 | |
| 58.4× | 48 | |
| 71.3× | 52 | |
| 40.6× | 0 | |
| 360.5× | 98 |
Loading peers and related research…
About this history
- What is BSX's current P/E?
- Boston Scientific's P/E of 17.3x is lower than 99% of its weekly readings over the last five years (as of Oct 30, 2026).
- What is BSX's five-year median P/E?
- 68.1x. Half of BSX's weekly readings over the last five years were higher and half were lower. This page has 861 weekly readings, from May 3, 2010 to Oct 26, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank compares BSX only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.